A small molecule selective CYP51 inhibitor for the treatment of recurrent vulvovaginal—oteseconazole

doi:10.3969/j.issn.1672-3384.2023.05.003

PDF(427 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (5) : 12-16. DOI: 10.3969/j.issn.1672-3384.2023.05.003

Comment of New Drug

A small molecule selective CYP51 inhibitor for the treatment of recurrent vulvovaginal—oteseconazole

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(5): 12-16 https://doi.org/10.3969/j.issn.1672-3384.2023.05.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(427 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-02-18	2023-05-30
Issue Date
2023-05-30

Please choose a citation manager

Content to export